Alajar´ın et al.
>99%; mp 174-176 °C (colorless prisms, CHCl3/Et2O); IR (nujol)
2-Phenyl-4-[(E)-3-phenyl-1-butenyl]thiazole (4a).53 AcOEt/
hexane (1:20) was used as eluent (Rf 0.36). Yield 63%; yellow oil;
1785, 1714, 1545, 1506, 1492, 1426, 1269, 1145, 1269, 1145, 769,
1
1
692 cm-1; H NMR (CDCl3) δ 5.83 (t, 1H, J ) 3.5 Hz), 6.02 (t,
IR (neat) 1488, 1451, 1275, 1107, 1003, 967, 762, 690 cm-1; H
1H, J ) 3.0 Hz), 6.11 (dd, 1H, J ) 3.8 Hz, J ) 2.9 Hz), 7.32-
7.36 (m, 3H), 7.40-7.45 (m, 6H), 7.47-7.51 (m, 2H), 7.55-7.60
(m, 1H), 7.94-7.97 (m, 2H); 13C NMR (CDCl3) δ 56.1 (d), 65.4
(d), 116.2 (d), 125.0 (2 × d), 128.40 (d), 128.41 (2 × d), 128.9 (2
× d), 129.08 (2 × d), 129.12 (2 × d), 129.8 (2 × d), 130.6 (s),
132.0 (s), 132.9 (d), 134.5 (s), 135.2 (s), 149.8 (s), 153.6 (s), 155.1
(s), 173.9 (s). MS (EI, 70 eV) m/z (rel intensity) 472 (M+, 1), 299
(25), 298 (25), 297 (68), 296 (40), 194 (46), 177 (30), 149 (45),
121 (100), 119 (88), 115 (72), 104 (33), 91 (52), 64 (39). Anal.
Calcd for C25H17ClN4O2S (472.95): C, 63.49; H, 3.62; N, 11.85;
S, 6.78. Found: C, 63.23; H, 3.72; N, 11.89; S, 6.90.
NMR (CDCl3) δ 1.41 (d, 3H, J ) 7.0 Hz), 3.59 (quintd, 1H, J )
6.9 Hz, J ) 1.3 Hz), 6.35 (dd, 1H, J ) 15.6 Hz, J ) 1.3 Hz), 6.80
(dd, 1H, J ) 15.6 Hz, J ) 6.8 Hz), 6.88 (s, 1H), 7.11-7.15 (m,
1H), 7.20-7.26 (m, 4H), 7.30-7.34 (m, 3H), 7.86-7.88 (m, 2H);
13C NMR (CDCl3) δ 21.1 (q), 42.4 (d), 113.6 (d), 121.8 (d), 126.2
(d), 126.6 (2 × d), 127.4 (2 × d), 128.5 (2 × d), 128.8 (2 × d),
129.9 (d), 133.6 (s), 138.5 (d), 145.3 (s), 155.0 (s), 167.7 (s). MS
(EI, 70 eV) m/z (rel intensity) 291 (M+, 46), 238 (32), 217 (30),
188 (30), 135 (100), 105 (69), 103 (53), 77 (61).
General Procedure for the Synthesis of the PTAD Adducts
8 and 9. PTAD (0.13 g, 0.75 mmol) was added to a solution of the
corresponding 4-alkenylthiazole 4 (0.75 mmol) in toluene (5 mL),
precooled at -5 °C. The reaction mixture was stirred at the same
temperature for 30 min. The solvent was removed under reduced
pressure and the residue purified by silica gel column chromatog-
raphy. Only the mixture of diastereoisomers 8a and 9a could be
resolved. The other two examples, 8b/9b and 8c/9c, were isolated
as diastereomeric mixtures (Supporting Information).
(4R*,5R*)-5-(4-Chlorophenyl)-2,8-diphenyl-4-(4-phenyl-3,5-
dioxo-1,2,4-triazolidin-1-yl)-4,5-dihydrothiazolo[5,4-c][1,2,4]-
triazolo[1,2-a]pyridazin-7,9-dione (3a). PTAD (0.02 g, 0.11
mmol) was added to a solution of 2a (0.05 g, 0.11 mmol) in toluene
(5 mL). The reaction mixture was stirred under reflux for 20 min.
After removal of the solvent under reduced pressure, the residue
was purified by silica gel column chromatography eluting with 1:1
AcOEt/hexane (Rf 0.33). Yield 97%; mp 164-166 °C (colorless
prisms, CHCl3/Et2O); IR (nujol) 1781, 1725, 1563, 1500, 1410,
(5R*,10aS*)-2,8-Diphenyl-5-[(1S*)-1-phenylethyl]-5,10a-dihy-
drothiazolo[5,4-c][1,2,4]triazolo[1,2-a]pyridazin-7,9-dione (8a).
AcOEt/hexane (1:2) was used as eluent (Rf 0.30). Yield 62%; mp
151-153 °C (colorless prisms, CHCl3/Et2O); IR (nujol) 1771, 1709,
1
760, 690 cm-1; H NMR (CDCl3) δ 5.89 (broad s, 1H), 5.95 (d,
1H, J ) 1.4 Hz), 7.20 (d, 2H, J ) 8.6 Hz), 7.31 (d, 2H, J ) 8.6
Hz), 7.33-7.44 (m, 13H), 7.84-7.86 (m, 2H), 8.67 (broad s, 1H,
NH); 13C NMR (CDCl3) δ 55.2 (d), 59.4 (d), 125.4 (2 × d), 125.6
(2 × d), 126.4 (2 × d), 128.2 (2 × d), 128.5 (d), 128.8 (d), 129.2
(2 × d), 129.25 (2 × d), 129.32 (2 × d), 129.6 (s), 129.7 (2 × d),
130.0 (s), 130.3 (s), 130.5 (s), 130.9 (d), 132.3 (s), 132.5 (s), 135.8
(s), 146.0 (s), 149.6 (s), 152.9 (s), 153.7 (s), 162.5 (s). MS (EI, 70
eV) m/z (rel intensity) 648 (M+ + 1, 15), 473 (43), 471 (90), 393
(49), 322 (92), 149 (100), 109 (53), 107 (47). Anal. Calcd for
C33H22ClN7O4S (648.09): C, 61.16; H, 3.42; N, 15.13; S, 4.95.
Found: C, 60.83; H, 3.59; N, 15.29; S, 5.07.
1
1541, 1419, 1273, 953, 852, 759, 684 cm-1; H NMR (CDCl3) δ
1.45 (d, 3H, J ) 7.3 Hz), 3.81 (quint, 1H, J ) 7.0 Hz), 5.09 (dt,
1H, J ) 6.2 Hz, J ) 3.5 Hz), 5.70 (t, 1H, J ) 3.0 Hz), 6.30 (dd,
1H, J ) 3.6 Hz, J ) 2.9 Hz), 7.10-7.12 (m, 2H), 7.20-7.24 (m,
3H), 7.39-7.57 (m, 8H), 7.87-7.89 (m, 2H); 13C NMR (CDCl3)
δ 17.4 (q), 41.8 (d), 57.6 (d), 64.5 (d), 113.8 (d), 125.3 (2 × d),
127.6 (d), 128.2 (4 × d), 128.4 (3 × d), 128.8 (2 × d), 129.3 (2 ×
d), 130.8 (s), 132.1 (s), 132.7 (d), 139.7 (s), 149.9 (s), 154.0 (s),
154.1 (s), 173.3 (s). MS (EI, 70 eV) m/z (rel intensity) 465 (M+
-
1, 39), 361 (73), 213 (27), 186 (36), 121 (38), 119 (32), 105 (100),
77 (27). Anal. Calcd for C27H22N4O2S (466.55): C, 69.51; H, 4.75;
N, 12.01; S, 6.87. Found: C, 69.34; H, 4.80; N, 11.92; S, 6.95.
(5R*,10aS*)-2,8-Diphenyl-5-[(1R*)-1-phenylethyl]-5,10a-dihy-
drothiazolo[5,4-c][1,2,4]triazolo[1,2-a]pyridazin-7,9-dione (9a).
AcOEt/hexane (1:2) was used as eluent (Rf 0.33). Yield 31%; mp
112-114 °C (colorless prisms, CHCl3/n-hexane); IR (nujol) 1774,
General Procedure for the Preparation of R-Chloroketones
7a-c. The corresponding aldehyde 6 (14.15 mmol) was added to
a suspension of 552 (2.00 g, 2.83 mmol) in dry toluene (25 mL)
and the reaction mixture was stirred at room temperature or 40 °C
(for exact temperature and reaction times see every particular case
in Table 2). After removal of all volatiles under reduced pressure,
the residue was purified by silica gel column chromatography.
(E)-1-Chloro-5-phenyl-3-hexen-2-one (7a). Temperature and
reaction time: 25 °C, 7 days. AcOEt/hexane (1:5) was used as
eluent (Rf 0.63). Yield 80% (yellow liquid); IR (neat) 1712, 1697,
1626, 1601, 1493, 1452, 1399, 1292, 1177, 1076, 1013, 978, 761,
1714, 1541, 1501, 1409, 1260, 953, 761, 687 cm-1 1H NMR
;
(CDCl3) δ 1.34 (d, 3H, J ) 7.2 Hz), 3.91 (qd, 1H, J ) 7.1 Hz, J
) 4.7 Hz), 5.04 (dt, 1H, J ) 4.7 Hz, J ) 3.4 Hz), 5.87 (t, 1H, J )
3.1 Hz), 5.93 (t, 1H, J ) 3.1 Hz), 7.27-7.31 (m, 1H), 7.35-7.42
(m, 5H), 7.45-7.51 (m, 4H), 7.53-7.57 (m, 3H), 7.90-7.92 (m,
2H); 13C NMR (CDCl3) δ 13.2 (q), 40.8 (d), 58.3 (d), 65.3 (d),
113.5 (d), 125.2 (2 × d), 127.2 (d), 128.0 (2 × d), 128.3 (2 × d),
128.4 (d), 128.7 (2 × d), 128.8 (2 × d), 129.2 (2 × d), 130.8 (s),
132.1 (s), 132.7 (d), 140.5 (s), 149.0 (s), 154.3 (s), 155.1 (s), 173.1
(s). MS (EI, 70 eV) m/z (rel intensity) 466 (M+, 21), 464 (36), 376
(40), 361 (89), 316 (55), 215 (70), 121 (63), 119 (72), 105 (100),
103 (51), 91 (55), 77 (68). Anal. Calcd for C27H22N4O2S (466.55):
C, 69.51; H, 4.75; N, 12.01; S, 6.87. Found: C, 69.13; H, 4.88; N,
12.21; S, 6.99.
Synthesis of Compounds 10a and 11a. PTAD (0.02 g, 0.11
mmol) was added to a solution of 8a or 9a (0.05 g, 0.11 mmol) in
toluene (5 mL). The reaction mixture was stirred at room temper-
ature for 12 h. After removal of the solvent under reduced pressure,
the residue was purified by silica gel column chromatography.
(4R*,5R*)-2,8-Diphenyl-4-(4-phenyl-3,5-dioxo-1,2,4-triazoli-
din-1-yl)-5-[(1S*)-1-phenylethyl]-4,5-dihydrothiazolo[5,4-c][1,2,4]-
triazolo[1,2-a]pyridazin-7,9-dione (10a). AcOEt/hexane (1:1) was
used as eluent (Rf 0.37). Yield 92%; mp 164-166 °C (colorless
1
700 cm-1; H NMR (CDCl3) δ 1.44 (d, 3H, J ) 6.9 Hz), 3.65
(quintd, 1H, J ) 6.9 Hz, J ) 1.5 Hz), 4.20 (s, 2H), 6.27 (dd, 1H,
J ) 15.9 Hz, J ) 1.5 Hz), 7.11 (dd, 1H, J ) 15.9 Hz, J ) 6.9 Hz),
7.16-7.23 (m, 2H), 7.24-7.27 (m, 1H), 7.29-7.35 (m, 2H); 13C
NMR (CDCl3) δ 20.0 (q), 42.3 (d), 47.0 (t), 124.5 (d), 126.9 (d),
127.2 (2 × d), 128.7 (2 × d), 142.6 (s), 153.5 (d), 191.2 (s). MS
(EI, 70 eV) m/z (rel intensity) 210 (M+ + 2, 17), 208 (M+, 54),
173 (46), 159 (89), 144 (64), 141 (53), 134 (45), 131 (100), 129
(95), 116 (46), 115 (55), 105 (74), 103 (44), 91 (58), 79 (41), 77
(62). HRMS (EI): m/z calcd for C12H13ClO 208.065493, found
208.065532.
General Procedure for the Preparation of 4-Alkenylthiazoles
4a-c. Thiobenzamide (0.62 g; 4.50 mmol) was added to a solution
of the corresponding R-haloketone 7 (3.00 mmol) in ethanol
(50 mL) and the reaction mixture was stirred under reflux for 5 h.
The solvent was removed under reduced pressure and 5% NaHCO3
aqueous solution (50 mL) was added. Then, the reaction mixture
was extracted with CH2Cl2 (3 × 50 mL). The combined organic
extracts were dried with MgSO4. The solvent was removed and
the residue was purified by silica gel column chromatography.
(53) Thiazole 7a was obtained with minor impurities after purification
by column chromatography. It was used for the next step without further
purification. The NMR spectra shown in the Supporting Information were
obtained from a first fraction obtained in a second chromatography.
(52) Hudson, R. F.; Chopard, P. A. J. Org. Chem. 1963, 28, 2446-
2447.
972 J. Org. Chem., Vol. 73, No. 3, 2008